BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 47 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $364,000 | +22.6% | 295,007 | -16.3% | 0.00% | 0.0% |
| Q1 2020 | $297,000 | -98.8% | 352,415 | -98.8% | 0.00% | -98.9% |
| Q4 2019 | $24,085,000 | +0.5% | 28,500,000 | -23.0% | 0.09% | -1.1% |
| Q3 2019 | $23,956,000 | – | 37,000,000 | -51.3% | 0.09% | – |
| Q2 2019 | $0 | – | 76,000,000 | +198.0% | 0.00% | – |
| Q1 2019 | $0 | – | 25,500,000 | +12.3% | 0.00% | – |
| Q4 2018 | $0 | – | 22,708,000 | +4326.5% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 513,000 | -0.8% | 0.00% | -100.0% |
| Q2 2017 | $615,000 | -66.5% | 517,000 | -66.7% | 0.00% | -60.0% |
| Q1 2017 | $1,834,000 | +1379.0% | 1,553,000 | +1569.9% | 0.01% | – |
| Q4 2015 | $124,000 | -98.4% | 93,000 | -98.1% | 0.00% | -100.0% |
| Q2 2015 | $7,947,000 | +7190.8% | 4,990,000 | +6830.6% | 0.02% | – |
| Q1 2015 | $109,000 | – | 72,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 6,195,000 | $9,377,000 | 2.84% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $10,750,000 | 1.09% |
| Man Investments (CH) AG | 1,100,000 | $1,482,000 | 0.73% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 22,554,000 | $30,444,000 | 0.47% |
| SSI INVESTMENT MANAGEMENT LLC | 3,124,000 | $4,202,000 | 0.45% |
| ARROWGRASS CAPITAL PARTNERS (US) LP | 20,000 | $22,373,000 | 0.42% |
| Calamos Advisors LLC | 35,219,000 | $47,628,000 | 0.33% |
| LINDEN ADVISORS LP | 2,500,000 | $3,370,000 | 0.23% |
| Calamos Wealth Management LLC | 513,000 | $694,000 | 0.17% |
| LOOMIS SAYLES & CO L P | 477,810 | $50,323,000 | 0.15% |